Sanofi Pasteur sends yellow fever vacc to combat epidemic

3 March 2008

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, says that it has shipped six million doses of its Stamaril vaccine in response to a UNICEF request for aid in combating the yellow fever epidemic currently sweeping Latin America. The firm explained that, under UNICEF's stockpiling program, Brazil received four million of the doses, with neighbor Paraguay being provided with the remainder.

Sanofi Pasteur's chief executive, Wayne Pisano, said that the firm had "mobilized its teams to make this public health emergency a priority." Over the past 20 years the company has provided around 200 million doses of yellow fever vaccine to more than 150 countries worldwide.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight